A third of healthcare workers took sick leave after COVID-19 vaccination, German study finds

An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers

22 Apr 2022
Dora Wells
Clinical Content Editor

Industry news

A third of healthcare workers took sick leave after being vaccinated against COVID-19, a German study presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April) has found.

A healthy healthcare workforce is vital to cope with COVID-19, as well as with the pandemic’s wider effects on public health. As a result, many countries have prioritized the vaccination of healthcare workers.

Little information is available, however, on the incidence of side-effects in healthcare workers. This is important because, if it leads to them taking time off, it could put already under-pressure healthcare systems under extra strain.

To find out more, Julia Reusch, of the University Hospital Würzburg, Würzburg, Germany and her colleagues Isabell Wagenhäuser, Dr. Alexander Gabel, Dr. Manuel Krone and Dr. Nils Petri evaluated healthcare workers given at least one dose of the four following COVID-19 vaccines: BioNTech/Pfizer (Comirnaty), Moderna (Spikevax), Oxford/AstraZeneca (VaxZevria) and Janssen.

An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers (aged 18-plus) in the study. Side effects included in the questionnaire included local vaccination reactions (swelling, redness, or pain around injection site), headaches, aching limbs, fever and/or chills, and fatigue.

588 healthcare workers (32.72%) took sick leave overall, amounting to 1,777 sick days. Average length of sick leave was two days.

Workers were most likely to take sick leave after the third dose of the vaccine. While only 5.65% of the participants took a sick leave after their first administration (mostly after receiving a vector vaccine), 20.66% took a sick leave after the second dose, and 27.31% after the third one.

Median length of sick leave was 2 days and lasted up to 47 days.

Most of the 5.65% of the participants took sick leave after their first dose of the vaccine. Most of these had been given the viral vector vaccines (Oxford/AstraZeneca and Janssen). (Changes to the vaccine regimen in Germany meant that not enough healthcare workers had second or third doses of vector vaccines for the information to be included in the study.)

Those given the mRNA jabs (BioNTech/Pfizer and Moderna) were most likely to take sick leave after their second or third dose.

Sick leave after the third dose was significantly longer after the Moderna vaccine than the BioNTech/Pfizer vaccine.

The relative number of self-reported side effects decreased from first to second to third vaccination.

There were significant differences in the number of side effects reported by those who received the BioNTech/Pfizer and Moderna vaccines. Significantly higher rates of side effects were reported after the second and third dose of the BioNTech/Pfizer vaccine compared to the Moderna vaccine.

Ms. Reusch says: “A considerable number of healthcare workers took sick days after vaccination. The timing of the side effects varied according to the vaccine used. Those given viral vector vaccines were most likely to take sick leave after their first dose and there were higher rates of sick leave after the third dose of the Moderna vaccine than the BioNTech vaccine.

“The number of side effects and consequent time off after COVID-19 vaccination of healthcare workers is not negligible and should be further investigated.”

The participants were members of the CoVacSer study, which is examining the course of COVID-19 antibodies, quality of life, and ability to work over time.

Find news coverage of ECCMID by SelectScience by clicking here >>

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.ECCMIDVirusesViruses are microscopic pathogens that require a host cell to replicate. Understanding their structure, replication cycle, and impact on the immune system is crucial in developing effective treatments, vaccines, and diagnostic methods. Research continues to focus on emerging viral diseases and antiviral drug discovery. Explore solutions for virus research, detection, and treatment in our peer-reviewed product directory; compare products, check customer reviews, and get pricing directly from manufacturers.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.Infectious DiseasesInfectious diseases are caused by pathogens such as bacteria, viruses, and fungi. Effective detection, prevention, and treatment are crucial to control outbreaks and improve public health. Diagnostic tools, vaccines, and antimicrobial treatments are essential components of managing these diseases. Research into emerging pathogens and resistance patterns continues to evolve. Browse our peer-reviewed product directory to find the best diagnostic tools, prevention solutions, and treatment options; compare products, read customer reviews, and get pricing directly from manufacturers.
A third of healthcare workers took sick leave after COVID-19 vaccination, German study finds